| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.43B | 15.16B | 14.18B | 14.27B | 12.14B | 11.67B |
| Gross Profit | 2.89B | 2.48B | 816.69M | 1.60B | 1.26B | 1.60B |
| EBITDA | 6.57B | 6.14B | 5.05B | 6.25B | 5.67B | 5.70B |
| Net Income | 956.45M | 5.11B | 146.64M | 876.04M | 882.83M | 161.56M |
Balance Sheet | ||||||
| Total Assets | 73.98B | 77.93B | 71.35B | 71.56B | 74.44B | 69.79B |
| Cash, Cash Equivalents and Short-Term Investments | 8.12B | 9.23B | 4.41B | 4.38B | 4.49B | 1.44B |
| Total Debt | 42.44B | 45.54B | 44.69B | 48.02B | 53.39B | 50.62B |
| Total Liabilities | 49.42B | 52.87B | 51.99B | 53.67B | 59.32B | 55.89B |
| Stockholders Equity | 24.57B | 25.06B | 19.37B | 17.89B | 15.12B | 13.90B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.38B | 2.79B | 3.22B | -3.48B | -5.66B |
| Operating Cash Flow | 0.00 | 4.71B | 6.04B | 4.92B | 6.03B | 4.33B |
| Investing Cash Flow | 0.00 | -2.14B | -2.61B | 433.47M | -5.62B | -7.11B |
| Financing Cash Flow | 0.00 | 565.29M | -3.49B | -5.53B | 2.62B | 2.91B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥1.73T | 10.15 | 11.32% | 5.12% | -2.96% | -10.12% | |
79 Outperform | ¥2.53T | 6.29 | 10.90% | 5.81% | 0.36% | -14.86% | |
77 Outperform | ¥191.30B | 7.21 | ― | 4.08% | -10.66% | -17.73% | |
76 Outperform | ¥180.75B | 5.06 | 13.08% | 3.75% | -7.72% | 27.03% | |
74 Outperform | ¥22.82B | 3.25 | ― | 1.29% | 4.21% | 35.32% | |
65 Neutral | ¥18.17B | 1,812.20 | ― | 5.77% | 3.22% | -87.75% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |